Passage Bio, Inc.
PASG
$7.35
-$0.29-3.80%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -20.46% | -25.96% | -17.92% | -15.46% | -17.48% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -33.78% | -32.10% | -29.18% | -28.45% | -28.93% |
| Operating Income | 33.78% | 32.10% | 29.18% | 28.45% | 28.93% |
| Income Before Tax | 29.71% | 34.21% | 25.75% | 24.84% | 36.54% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 29.71% | 34.21% | 25.75% | 24.84% | 36.54% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 29.71% | 34.21% | 25.75% | 24.84% | 36.54% |
| EBIT | 33.78% | 32.10% | 29.18% | 28.45% | 28.93% |
| EBITDA | 31.67% | 30.77% | 28.45% | 28.37% | 29.43% |
| EPS Basic | 31.90% | 38.15% | 33.01% | 34.02% | 43.14% |
| Normalized Basic EPS | 36.10% | 37.32% | 36.87% | 38.25% | 37.34% |
| EPS Diluted | 31.90% | 38.15% | 33.01% | 34.02% | 43.18% |
| Normalized Diluted EPS | 36.10% | 37.32% | 36.87% | 38.25% | 37.34% |
| Average Basic Shares Outstanding | 3.08% | 6.39% | 9.89% | 13.72% | 11.93% |
| Average Diluted Shares Outstanding | 3.08% | 6.39% | 9.89% | 13.72% | 11.93% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |